Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin

Polymeric inserts containing azithromycin-loaded Eudragit<sup>®</sup> L100 nanoparticles were developed to sustain the drug release and enhance its ocular performance. The solvent diffusion technique was employed to prepare nanoparticles. The developed nanoparticles (NPs) were fully char...

Full description

Bibliographic Details
Main Authors: Shiva Taghe, Shahla Mirzaeei, Raid G. Alany, Ali Nokhodchi
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/8/11/466
id doaj-5d8c2b50e6384b029cd36e808e8b10ba
record_format Article
spelling doaj-5d8c2b50e6384b029cd36e808e8b10ba2020-11-25T03:58:31ZengMDPI AGBiomedicines2227-90592020-10-01846646610.3390/biomedicines8110466Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of AzithromycinShiva Taghe0Shahla Mirzaeei1Raid G. Alany2Ali Nokhodchi3Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6714415153, IranPharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6714415153, IranDrug Discovery, Delivery and Patient Care (DDDPC), School of Life Sciences, Pharmacy and Chemistry, Kingston University, London KT1 2EE, UKPharmaceutics Research Laboratory, School of Life Sciences, University of Sussex, Brighton BN1 9QJ, UKPolymeric inserts containing azithromycin-loaded Eudragit<sup>®</sup> L100 nanoparticles were developed to sustain the drug release and enhance its ocular performance. The solvent diffusion technique was employed to prepare nanoparticles. The developed nanoparticles (NPs) were fully characterized and investigated. The solvent casting method was used to prepare azithromycin ocular inserts (azithromycin, AZM film) by adding hydroxypropyl methylcellulose (HPMC) or hydroxyethyl cellulose (HEC) solutions after the incorporation of AZM-loaded Eudragit<sup>®</sup> L100 nanoparticles into plasticized PVA (polyvinyl alcohol) solutions. The optimized nanoparticles had a particle size of 78.06 ± 2.3 nm, zeta potential around −2.45 ± 0.69 mV, polydispersity index around 0.179 ± 0.007, and entrapment efficiency 62.167 ± 0.07%. The prepared inserts exhibited an antibacterial effect on <i>Staphylococcus aureus</i> and <i>Escherichia coli</i> cultures. The inserts containing AZM-loaded nanoparticles showed a burst release during the initial hours, followed by a sustained drug release pattern. Higher cumulative corneal permeations from AZM films were observed for the optimized formulation compared to the drug solution in the ex-vivo trans-corneal study. In comparison to the AZM solution, the inserts significantly prolonged the release of AZM in rabbit eyes (121 h). The mucoadhesive inserts containing azithromycin-loaded Eudragit<sup>®</sup> L100 nanoparticles offer a promising approach for the ocular delivery of azithromycin (antibacterial and anti-inflammatory) to treat ocular infections that require a prolonged drug delivery.https://www.mdpi.com/2227-9059/8/11/466Azithromycincontrolled drug deliveryEudragit<sup>®</sup> L100 nanoparticlesmucoadhesive filmsocular drug delivery
collection DOAJ
language English
format Article
sources DOAJ
author Shiva Taghe
Shahla Mirzaeei
Raid G. Alany
Ali Nokhodchi
spellingShingle Shiva Taghe
Shahla Mirzaeei
Raid G. Alany
Ali Nokhodchi
Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin
Biomedicines
Azithromycin
controlled drug delivery
Eudragit<sup>®</sup> L100 nanoparticles
mucoadhesive films
ocular drug delivery
author_facet Shiva Taghe
Shahla Mirzaeei
Raid G. Alany
Ali Nokhodchi
author_sort Shiva Taghe
title Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin
title_short Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin
title_full Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin
title_fullStr Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin
title_full_unstemmed Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin
title_sort polymeric inserts containing eudragit<sup>®</sup> l100 nanoparticle for improved ocular delivery of azithromycin
publisher MDPI AG
series Biomedicines
issn 2227-9059
publishDate 2020-10-01
description Polymeric inserts containing azithromycin-loaded Eudragit<sup>®</sup> L100 nanoparticles were developed to sustain the drug release and enhance its ocular performance. The solvent diffusion technique was employed to prepare nanoparticles. The developed nanoparticles (NPs) were fully characterized and investigated. The solvent casting method was used to prepare azithromycin ocular inserts (azithromycin, AZM film) by adding hydroxypropyl methylcellulose (HPMC) or hydroxyethyl cellulose (HEC) solutions after the incorporation of AZM-loaded Eudragit<sup>®</sup> L100 nanoparticles into plasticized PVA (polyvinyl alcohol) solutions. The optimized nanoparticles had a particle size of 78.06 ± 2.3 nm, zeta potential around −2.45 ± 0.69 mV, polydispersity index around 0.179 ± 0.007, and entrapment efficiency 62.167 ± 0.07%. The prepared inserts exhibited an antibacterial effect on <i>Staphylococcus aureus</i> and <i>Escherichia coli</i> cultures. The inserts containing AZM-loaded nanoparticles showed a burst release during the initial hours, followed by a sustained drug release pattern. Higher cumulative corneal permeations from AZM films were observed for the optimized formulation compared to the drug solution in the ex-vivo trans-corneal study. In comparison to the AZM solution, the inserts significantly prolonged the release of AZM in rabbit eyes (121 h). The mucoadhesive inserts containing azithromycin-loaded Eudragit<sup>®</sup> L100 nanoparticles offer a promising approach for the ocular delivery of azithromycin (antibacterial and anti-inflammatory) to treat ocular infections that require a prolonged drug delivery.
topic Azithromycin
controlled drug delivery
Eudragit<sup>®</sup> L100 nanoparticles
mucoadhesive films
ocular drug delivery
url https://www.mdpi.com/2227-9059/8/11/466
work_keys_str_mv AT shivataghe polymericinsertscontainingeudragitsupsupl100nanoparticleforimprovedoculardeliveryofazithromycin
AT shahlamirzaeei polymericinsertscontainingeudragitsupsupl100nanoparticleforimprovedoculardeliveryofazithromycin
AT raidgalany polymericinsertscontainingeudragitsupsupl100nanoparticleforimprovedoculardeliveryofazithromycin
AT alinokhodchi polymericinsertscontainingeudragitsupsupl100nanoparticleforimprovedoculardeliveryofazithromycin
_version_ 1724456845152616448